Stock Traders Buy High Volume of Call Options on agilon health (NYSE:AGL)

agilon health, inc. (NYSE:AGL) saw some unusual options trading on Friday. Investors bought 6,103 call options on the company. This represents an increase of 471% compared to the typical volume of 1,069 call options.

Institutional Investors Weigh In On agilon health

Several hedge funds and other institutional investors have recently made changes to their positions in AGL. Oak Thistle LLC acquired a new stake in shares of agilon health during the 4th quarter worth about $25,000. Ieq Capital LLC acquired a new stake in shares of agilon health during the 4th quarter worth about $26,000. Signaturefd LLC grew its stake in agilon health by 143.0% during the 4th quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after buying an additional 8,467 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health during the 3rd quarter worth approximately $28,000. Finally, Humankind Investments LLC purchased a new position in agilon health during the 4th quarter worth approximately $30,000.

agilon health Price Performance

Shares of NYSE AGL opened at $4.51 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The firm has a market capitalization of $1.86 billion, a PE ratio of -4.80 and a beta of 0.67. The stock’s 50-day simple moving average is $3.51 and its 200-day simple moving average is $2.95.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Royal Bank of Canada raised their target price on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a report on Wednesday, February 26th. Sanford C. Bernstein raised their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and raised their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Stifel Nicolaus raised their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a report on Wednesday, February 26th. Finally, Macquarie started coverage on agilon health in a report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $3.95.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.